Clinic Evaluation of The Destrovir Spray Effectiveness in SARS-CoV-2 Disease
Open Access
- 20 January 2022
- journal article
- research article
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 19 (2) , em357
Abstract
In late 2019 on 11th March 2020 a novel coronavirus, SARS-CoV-2 causing Coronavirus disease 2019 (COVID-19) appeared in Wuhan, China and World Health Organisation declared it to have developed pandemic status. Although there are many detection techniques for the disease to control the pandemic such as RT-PCR, serological methods, or fast antigen tests, the actual problem is the prevention of the disease. The nasal cavity and rhino pharynx are key sites of the initial replication of SARS-CoV-2. In this article, the effectiveness of destrovir spray was investigated by creating a mechanical barrier in the nasal and oral mucosa, which are the entry points of the virus into the body, and to destroy the virus that comes into contact with this barrier. In the presented study, quantitation cycle (Cq) and irradiation values (RFU) of 12 different high-positive patients (Cq≤25) after application of both RT-PCR and destrovir spray were determined at different concentrations (10%, 20%, 30%, 40%, and 50%) aimed to evaluate its effectiveness. According to the results obtained by comparing the effectiveness of disinfectant with 70% ethyl alcohol on the 46 patient samples with Cq<20, 46 patient samples with Cq values between 20-25, and 46 patient samples with Cq≥25 including different variants are examined. A total of 138 COVID-19 patient samples were treated with 5% and 10% ratios of destrovir spray. Its effectiveness on Cq values and RFU was evaluated and it was aimed to compare the effectiveness of this evaluation with 96% ethyl alcohol used in the same samples.Keywords
This publication has 14 references indexed in Scilit:
- Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infectionJournal of Infection, 2021
- Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferretsScience, 2021
- Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trialAmerican Journal of Otolaryngology, 2021
- COVID-19 and anosmia: A review based on up-to-date knowledgeAmerican Journal of Otolaryngology, 2020
- Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivityJournal of Clinical and Translational Science, 2020
- Upper airway symptoms in coronavirus disease 2019 (COVID-19)American Journal of Otolaryngology, 2020
- Efficacy of ethanol against viruses in hand disinfectionJournal of Hospital Infection, 2018
- Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal SpraysAdvances in Therapy, 2017
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- Cholinesterase inhibitors for Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006